Aptamers Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Aptamers Market Report is Segmented by Type (Nucleic Acid and Peptide), Application (Diagnostics, Therapeutics, Research and Development, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Aptamers Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Aptamers Market Size

Global Aptamers Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 2.05 Billion
Market Size (2030) USD 4.03 Billion
CAGR (2025 - 2030) 14.49 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration High

Major Players

aptamers market size

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Aptamers Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Aptamers Market Analysis

The Global Aptamers Market size is estimated at USD 2.05 billion in 2025, and is expected to reach USD 4.03 billion by 2030, at a CAGR of 14.49% during the forecast period (2025-2030).

Some of the factors that are driving the market growth include the high advantage of aptamers compared to antibodies, advancements in the field of aptamer development technologies, and growing investment in companies and research institutes.

Numerous advantages offered by these small molecules in comparison to established antibodies have also led to higher demand for these molecules across a diverse range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate market growth. According to a research study published in Nature Review in June 2024, aptamers provide distinct advantages, such as reduced production costs, enhanced thermal stability, and an extended shelf life. In contrast to antibodies, which often face batch-to-batch variability and demand intricate production methods involving animals, aptamers can be swiftly and consistently synthesized using in vitro techniques like SELEX (Systematic Evolution of Ligands by Exponential Enrichment). Furthermore, aptamers exhibit remarkable flexibility and adaptability, enabling them to bind to a diverse array of targets, from small molecules to proteins. Their compact size not only facilitates improved tissue penetration but also minimizes toxicity. Thus, such benefits associated with aptamers over the antibodies are expected to increase its demand over the forecast period.

The market players are adopting various strategies, such as product launches, developments, collaborations, partnerships, and expansions, to increase their market share. For instance, in June 2023, Zentek Ltd. announced that its aptamer platform, globally licensed exclusively from McMaster University Canada showed promise as a potential prophylactic or therapeutic for SARS-CoV-2 in pre-clinical animal models. In multiple trials, the aptamers, developed by Dr. Yingfu Li, exhibited comparable efficacy against SARS-CoV-2 when measured against a commercial monoclonal antibody.

Thus, all the aforementioned factors are expected to boost the market over the forecast period. However, unfavorable pharmacokinetic properties of aptamers, a low awareness level, and incomplete regulatory policies may hamper the overall market growth.

Aptamers Industry Overview

The Aptamers Market is consolidated with the presence of a few major market players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position. Some of the market players include Aptagen, LLC, Aptamer Sciences Inc., Base Pair Biotechnologies Inc., Aptamer Group, Aptus Biotech S.L., among others.

Aptamers Market Leaders

  1. Aptagen, LLC

  2. Aptamer Sciences Inc.

  3. Base Pair Biotechnologies Inc.

  4. Aptamer Group

  5. Aptus Biotech S.L.

  6. *Disclaimer: Major Players sorted in no particular order
Aptamers Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Aptamers Market News

  • October 2024: Astellas Pharma Inc. has decided to withdraw its marketing authorization application for avacincaptad pegol intravitreal solution (ACP) from the European Medicines Agency (EMA). ACP is an investigational synthetic aptamer that targets and inhibits the complement C5 protein, and it was being developed for the treatment of geographic atrophy (GA) linked to age-related macular degeneration (AMD).
  • October 2023: Zentek Ltd. has established a wholly-owned subsidiary, securing exclusive global licensing rights for all aptamer-based technologies from its collaboration with McMaster University Canada. This licensing deal encompasses both the rapid-detection platform and the newly developed aptamer-based technology, which Dr. Yingfu Li and his team pioneered. Notably, this technology is demonstrating therapeutic potential, as highlighted by ongoing preclinical studies led by Dr. Matthew Miller and his team.

Global Aptamers Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Advantage of Aptamers, Compared to Antibodies
    • 4.2.2 Advancements in the Field of Aptamer Development Technologies
    • 4.2.3 Growing Investment in the Companies and Research Institutes
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Pharmacokinetic Properties of Aptamers
    • 4.3.2 Low Awareness Level and Incomplete Regulatory Policies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Nucleic Acid
    • 5.1.2 Peptide
  • 5.2 By Application
    • 5.2.1 Diagnostics
    • 5.2.2 Therapeutics
    • 5.2.3 Research and Development
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AM Biotechnologies LLC
    • 6.1.2 Aptagen LLC
    • 6.1.3 Aptamer Sciences Inc.
    • 6.1.4 Aptamer Group
    • 6.1.5 Aptus Biotech S.L.
    • 6.1.6 Base Pair Biotechnologies Inc.
    • 6.1.7 NOXXON Pharma
    • 6.1.8 SomaLogic Inc.
    • 6.1.9 Baush Health Companies Inc.
    • 6.1.10 Maravai Lifesciences (Trilink Biotechnologies)
    • 6.1.11 NeoVentures Biotechnology, Inc.
    • 6.1.12 Vivonics, Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Aptamers Industry Segmentation

As per the scope of the report, aptamers are short, single-stranded DNA or RNA (ssDNA or ssRNA) molecules, that can selectively bind to a specific target, including peptides, proteins, small molecules, carbohydrates, toxins, and even live cells. Aptamers assume various shapes, owing to their tendency to form helices or single-stranded loops. These molecules are extremely versatile and are used to bind targets with high specificity and selectivity. The aptamers market is segmented by type, application, and geography. By type, the market is segmented into nucleic acid and peptide. By application, the market is segmented as diagnostics, therapeutics, research and development, and other applications. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.

By Type Nucleic Acid
Peptide
By Application Diagnostics
Therapeutics
Research and Development
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Global Aptamers Market Research Faqs

How big is the Global Aptamers Market?

The Global Aptamers Market size is expected to reach USD 2.05 billion in 2025 and grow at a CAGR of 14.49% to reach USD 4.03 billion by 2030.

What is the current Global Aptamers Market size?

In 2025, the Global Aptamers Market size is expected to reach USD 2.05 billion.

Who are the key players in Global Aptamers Market?

Aptagen, LLC, Aptamer Sciences Inc., Base Pair Biotechnologies Inc., Aptamer Group and Aptus Biotech S.L. are the major companies operating in the Global Aptamers Market.

Which is the fastest growing region in Global Aptamers Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Aptamers Market?

In 2025, the North America accounts for the largest market share in Global Aptamers Market.

What years does this Global Aptamers Market cover, and what was the market size in 2024?

In 2024, the Global Aptamers Market size was estimated at USD 1.75 billion. The report covers the Global Aptamers Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Aptamers Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Aptamers Industry Report

Statistics for the 2025 Global Aptamers market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Aptamers analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.